No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Thrombus Drug market is a subset of the Cardiovascular Drugs market, which focuses on the prevention and treatment of thrombus, or blood clots. Thrombus drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular events. These drugs work by preventing the formation of clots, or by dissolving existing clots. Commonly used thrombus drugs include anticoagulants, antiplatelet agents, and thrombolytics. Anticoagulants, such as warfarin and heparin, are used to prevent the formation of clots, while antiplatelet agents, such as aspirin and clopidogrel, are used to prevent the formation of clots and to reduce the risk of stroke. Thrombolytics, such as alteplase and streptokinase, are used to dissolve existing clots.
Some companies in the Thrombus Drug market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. Show Less Read more
